Product Information

DOXYLAMINE-PYRIDOXINE 10-10 MG is a generic product labeled by Bionpharma Inc., priced at $1.1455 per EA under NDC 69452020620. Its NADAC has been published 128 times since Mar 13, 2024.

FDA first approved this application on Aug 4, 2023. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

DOXYLAMINE-PYRIDOXINE 10-10 MG

Doxylamine succinate and Pyridoxine hydrochloride
$1.1455per EA

Strength

10; 10 mg/1; mg/1

Manufacturer

Bionpharma Inc.

NDC

69452020620

Classification

Generic

Dosage Form

TABLET, DELAYED RELEASE

Route

ORAL

Effective Date

8/19/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA217000

FDA Approved

8/4/2023

TE Code

AB

On Market Since

12/11/2023

Pharmacological Classes

Analogs/Derivatives [Chemical/Ingredient]
Antihistamine
Histamine Receptor Antagonists
Vitamin B 6 [Chemical/Ingredient]
Vitamin B6 Analog

Price Statistics

The NADAC for DOXYLAMINE-PYRIDOXINE 10-10 MG has been published 128 times since Mar 13, 2024, and over the history we have for it it has declined 46.2%. The table below summarizes its recorded NADAC range and movement.

Current price$1.1455 per EA
All-time high$2.3812 (Apr 10, 2024)
All-time low$0.9736 (Jul 17, 2024)
52-week high$1.3056
52-week low$1.1365
Median price$1.2212
Average price$1.2617
Largest weekly change+68.5% (Jun 19, 2024)
Weeks tracked128
Tracking sinceMar 13, 2024

Price History

1W

+0.8%

1M

+0.8%

3M

-9.3%

6M

-4.5%

1Y

-11.6%

3Y

N/A

5Y

N/A

All

-46.2%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Doxylamine succinate and Pyridoxine hydrochloride market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Frequently asked questions

What is the NADAC price of DOXYLAMINE-PYRIDOXINE 10-10 MG?

The current National Average Drug Acquisition Cost (NADAC) for DOXYLAMINE-PYRIDOXINE 10-10 MG, manufactured by Bionpharma Inc., is $1.1455 per EA (NDC 69452020620), effective Aug 19, 2026.

How has the price of DOXYLAMINE-PYRIDOXINE 10-10 MG changed over time?

Over the history we have for it, the NADAC for DOXYLAMINE-PYRIDOXINE 10-10 MG has declined 46.2%. It has been tracked across 128 weekly CMS publications since Mar 13, 2024.

What are the highest and lowest recorded NADAC prices for DOXYLAMINE-PYRIDOXINE 10-10 MG?

Since Mar 13, 2024, the NADAC for DOXYLAMINE-PYRIDOXINE 10-10 MG has ranged from a low of $0.9736 (Jul 17, 2024) to a high of $2.3812 (Apr 10, 2024), with a median of $1.2212 per EA.

Are there cheaper alternatives to DOXYLAMINE-PYRIDOXINE 10-10 MG?

No other NADAC-published product currently shares the active ingredient and strength of DOXYLAMINE-PYRIDOXINE 10-10 MG in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures DOXYLAMINE-PYRIDOXINE 10-10 MG?

DOXYLAMINE-PYRIDOXINE 10-10 MG (NDC 69452020620) is labeled by Bionpharma Inc., and CMS classifies it as a generic product.